Ozempic's potential to kill desire for alcohol focus of study
People using Ozempic say they are losing their desire to drink. It's anecdotal evidence right now, but this would be a game-changer for those who are trying to break free from addiction.
Drugs like Ozempic and Wegovy are used to treat Type 2 diabetes and obesity. The medicine mimics the behaviors of the natural hormone GLP-1, which controls appetite and regulates blood sugar.
Lawsuit alleges Ozempic, Wegovy cause bowel obstruction, stomach paralysis
An unintended consequence appears to be that people on the drugs are turning to the bottle less. They say their urge to drink has dramatically decreased.
A new clinical trial will study people of normal weight who are dependent on alcohol, notes Pat Aussem with the Partnership to End Addiction. Over five months, participants will get either Ozempic or a placebo, she said.
Dr. James Besante, chief medical officer at Sante Fe Recovery Center in New Mexico, agrees the study is exciting, but he cautions it's too early to tell whether the weight-loss drug will be effective for alcoholics.
'These treatments are still considered experimental for addiction,' he told 'Elizabeth Vargas Reports' on Thursday. 'And they're not covered by insurance when they're used for this purpose. And that's really important. It makes them inaccessible for many of the patients I see.'
He said there are already proven medications in the marketplace that are covered by insurance. If Ozempic proves to be effective, Besante said, it would effectively become another tool in the medical toolbelt.
'This is a really complex disease that affects different people differently,' he said. 'Rarely is there a magic pill or one medication that's going to solve this person's issue.'
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New York Post
3 hours ago
- New York Post
This must-have tool can prevent a silent, stealthy disease — every woman over 30 should know about it
It's time to get hip to this bone density and body composition test. Osteoporosis may seem like an old person's problem — the 'silent' condition gradually reduces bone mass and density, making your inner scaffolding weaker, thinner and more prone to fractures. The disease is actually becoming increasingly common among younger people due to poor eating habits, certain underlying health issues and medication use. Advertisement Dr. Pooja Gidwani, a concierge physician in L.A., is particularly worried about women taking GLP-1 drugs like Ozempic, which can cause a decrease in bone density along with rapid weight loss. 8 Osteoporosis makes bones weaker, thinner and more prone to fractures. It's becoming more prevalent in younger people. Evgeniy Kalinovskiy – She recommends women undergo a 'baseline' dual-energy X-ray absorptiometry (DEXA) scan in their early to mid-30s to help predict future health risks. The test measures the strength and quality of bones while also quantifying body fat, lean mass and visceral fat. Advertisement 'It's a favorite in research, clinical medicine and elite athletic programs for this reason,' Gidwani told The Post. Here's everything you need to know about this enlightening technology. How does a DEXA scan work? An X-ray provides detailed images of bone shape and structure, but it cannot accurately measure bone density or forecast fracture risk. Advertisement 8 In a DEXA scan (shown here), a high-energy and a low-energy X-ray beam are directed at your bones as you lie still on a padded table. dizfoto1973 – A DEXA scan harnesses the power of X-rays to reveal a clearer picture of bone strength. The machine directs two X-ray beams, one high-energy and one low-energy, at your bones as you lie still on a padded table. Advertisement The beams are absorbed by bone and soft tissue at different rates. The scanner detects this difference and calculates bone mineral density and body composition with an error rate typically within 1% to 2%. 'The scan is painless, noninvasive and usually takes less than 30 minutes start to finish,' Gidwani said. 'It uses far less radiation than a standard X-ray and is designed to catch bone loss well before it becomes visible or leads to fractures.' 8 Dr. Pooja Gidwani, a concierge physician in L.A., suggests women in their 30s undergo a DEXA scan, especially if they are taking GLP-1 drugs like Ozempic. Courtesy of Dr. Pooja Gidwani Gidwani noted that the exam doesn't involve injections or contrast dyes. She advised getting scanned in the morning. These tests are generally not recommended for pregnant women, and calcium supplement users may need to stop taking the tablets 24 hours beforehand. What can a DEXA scan reveal? Advertisement DEXA scans are primarily used to diagnose and monitor osteoporosis and osteopenia, a milder, earlier stage of bone loss. It can also detect nuanced conditions such as: Sarcopenia: low skeletal muscle mass Sarcopenic obesity: low muscle and high fat Osteosarcopenic obesity: low muscle, low bone density and high fat Abnormal visceral fat distribution linked to metabolic disease Unexplained fractures or suspected secondary osteoporosis (due to medications, hormonal disorders, etc.) 8 DEXA scans are primarily used to diagnose and monitor osteoporosis and osteopenia, a milder, earlier stage of bone loss, but they can also detect other concerning conditions. RFBSIP – Advertisement 'It's more reliable than body fat scales and more detailed than MRI for whole-body composition,' Gidwani said of DEXA. 'Its precision makes it ideal for tracking changes over time, especially during weight loss, strength training or hormone transitions like perimenopause and menopause.' Should I get a DEXA scan if I'm otherwise healthy? Bone mass tends to peak around age 30. The bone remodeling process continues, but the breakdown of old bone starts to slightly outpace the formation of new bone. Advertisement Genetics and personal habits such as diet, exercise, cigarette use and alcohol consumption influence bone health. Hormonal shifts — particularly a decrease in estrogen — can accelerate bone breakdown. 'Estrogen levels can begin to fluctuate in the mid-to-late 30s,' Gidwani explained, 'due to a range of factors, including early or natural perimenopausal transition, chronic stress, postpartum recovery, disrupted ovulatory cycles, low body fat, overtraining or preexisting gynecological or endocrine conditions like PCOS or hypothalamic amenorrhea.' 8 Hormonal shifts — particularly a decline in estrogen — can accelerate bone breakdown. Estrogen levels decrease in menopause. Valerii Honcharuk – Advertisement Women are also at risk of early bone density decline if they have a family history of early osteoporosis, a lack of strength training, insufficient calcium, protein or vitamin D intake, disordered eating, sedentary behavior or rapid weight loss. GLP-1 drugs, which suppress appetite, can cause speedy slimdowns. 'While GLP-1s can be incredibly helpful when done right, they can also lead to unintended losses in lean muscle and bone density if not paired with proper nutrition and resistance training,' said Gidwani, who treats women on GLP-1s and focuses on hormone health and longevity. 'In women in their 30s and 40s using GLP-1s,' she added, 'DEXA is especially valuable for detecting early loss of muscle or bone, often long before symptoms or complications arise.' 8 The loss of bone mass can accompany rapid weight loss with GLP-1 drugs like Ozempic. Wild Awake – Gidwani said she's seen female patients as young as 32 show low bone density on scans. For men, Gidwani suggests that those with a family history of osteopenia/osteoporosis, a history of fractures, long-term steroid use, low muscle mass, very low testosterone or long-term GLP-1 use consider a DEXA scan earlier than the standard guideline of age 70. Where can I get a DEXA scan? Hospitals, diagnostic imaging centers, women's health or endocrinology clinics and increasingly, wellness and fitness centers offer DEXA scans. 'Companies like BodySpec and DexaFit specialize in mobile or consumer-accessible DEXA scanning, often used for fitness tracking,' Gidwani said. 'Just be sure to confirm whether the scan is being done for diagnostic purposes (bone density) or wellness (body composition).' DEXA costs vary widely, from $40 to $300 or more out of pocket, depending on the facility, the extent of the scan and the specific reason for it. 8 Dismissing bone health in youth can lead to significant problems later in life. zinkevych – Scans are typically covered by insurance for women over the age of 65, men older than 70, postmenopausal women with risk factors, people with certain medical conditions or those taking medications that increase fracture risk. 'Hopefully, as awareness around early bone loss and changes in body composition increases (especially in the context of GLP-1 use and hormonal shifts in younger women),' Gidwani said, 'screening guidelines will begin to reflect this need for earlier, proactive intervention.' What are the treatment options for low bone density? If a scan reveals low bone density, the first step is to identify the cause. 8 Strength training stimulates bone growth and slows bone loss. Microgen – Gidwani said a treatment plan typically includes: Strength training to improve bone and muscle Increased protein intake — aim for at least 0.8 to 1.2 grams of protein per pound of body weight, especially if you're on GLP-1s or losing weight. Calcium and vitamin D supplementation Hormone therapy, particularly for perimenopausal and postpartum patients Fall prevention and balance training Lifestyle changes such as reducing alcohol intake, quitting smoking and addressing nutritional deficiencies In moderate to severe cases, medications like bisphosphonates and denosumab slow bone breakdown while teriparatide stimulates the formation of new bone. 'In your 30s or 40s, the most impactful strategy is prevention,' Gidwani said, 'identifying early losses, tailoring lifestyle interventions and checking progress over time with repeat DEXA scans.'
Yahoo
18 hours ago
- Yahoo
Mounjaro weight-loss drug price to almost triple in UK
The price of popular weight-loss jab Mounjaro will nearly triple after the US-owned company equalised costs in markets across the globe. A month's supply of the highest doses of the 'King Kong' of weight loss medicine will rise from £122 to £330 - an increase of 170 per cent. At least 500,000 people in the UK take either Mounjaro or Wegovy, another weight loss jab, via prescriptions from private online pharmacies, according to retailers. In June, the NHS offered Mounjaro to obese patients after health experts calculated from NHS England data that there were 97,500 patients who would benefit from the treatment. Mounjaro's owner Eli Lily said it would not raise the price paid by the NHS, and it was working with private healthcare providers to maintain access to the jab. The NHS said the price increase would not affect its commissioning of the medicine for people with obesity and type 2 diabetes. Eli Lilly launched Mounjaro in the UK in February last year, while rival Novo Nordisk's Wegovy treatment has been available in the country since September 2023. The company said when it launched Mounjaro in the UK, it agreed to a list price "significantly below" that in its three other European markets to prevent delays in availability through the NHS. 'We are now aligning the list price more consistently,' a spokesperson said. The move reflects how the pharmaceutical industry is navigating policy changes in the US, by far its most lucrative market. It comes after Donald Trump's administration complained about 'foreign freeloaders' who rely on the US to pay more for medicine. The US pays more for prescription drugs than any other country, often nearly three times as much as other developed nations. Mr Trump says he wants to narrow this gap to stop Americans from being "ripped off". In the UK, the NHS was told to offer Mounjaro to patients with a BMI of over 40 and at least four clinical conditions related to their weight, such as heart disease or type 2 diabetes. Over the next three years, about 240,000 patients are expected to be eligible for the treatment. It came after the National Institute for Health and Care Excellence (Nice) warned many individuals might regain weight if not adequately supported after ceasing treatment. It stressed that those coming off the drugs should be offered "structured advice and follow-up support" to mitigate weight gain. This guidance applies to individuals receiving these treatments through the NHS. The new 'quality standard' from Nice said NHS patients should be monitored for at least a year after they complete treatment, and extra support should be offered if needed. It emphasises building 'long-term behavioural habits, use self-monitoring tools, and draw on wider support – from online communities to family-led interventions and local activities'. This standard, a type of guidance for the health services in England and Wales, sets out expectations for health providers including how they should support patients. Weight-loss injections, also known as GLP-1 receptor agonists, work by mimicking the natural hormone which regulates blood sugar, appetite and digestion.
Epoch Times
20 hours ago
- Epoch Times
Cowboys Owner Jerry Jones Announces He Is Cancer Free With New Treatment
Longtime Dallas Cowboys owner Jerry Jones, now cancer free, recently went public on his battle with Stage 4 melanoma via an interview with The Dallas Morning News and an upcoming Netflix series about the Cowboys that will air on Aug. 19. 'I was saved by a fabulous treatment and great doctors and a real miracle [drug] called PD-1 [therapy],' Jones told the paper. 'I went into trials for that PD-1, and it has been one of the great medicines. I now have no tumors.'
